account_id none on file
legal_name ARS Pharmaceuticals, Inc.
ticker SPRY
cik 1671858
domain ars-pharma.com
linkedin_company_url https://www.linkedin.com/company/arspharmaceuticals/
entry_point_account_id none on file
name ARS Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 1 filings 0 executives 5 family 0
why_nownone on file
calls
As Rich said, you know, we looked across the entire marketing kind of commercial budget, and the things that we're taking down, like we looked last year at some of the large conferences, some of the regional conferences that we did, and we really did an analysis of the greatest impact in terms of And as Rich also said, we look to optimize kind of our spend from a media perspective, so some money from there. And then also just monies that the representatives use in the offices to bring in, you know, lunch and things along those lines, a very small portion. But, again, we feel very confident that this does not have any impact on our ability to execute what we need to do, but more important, pull through and the frequency that we see that really links to higher market share adoption is what we're excited about.
Mar 9, 2026 / receipt, needs a key / Eric, other | earnings call 2026-03-09 | transcript 23088f87-0389-419b-8ff7-cdc395e0a344 | chars 22282-23101 | segment 23
filingsnone on file
executives
| Brian T. Dorsey | Chief Operations Officer | - | receipt |
| Donn Casale | President | - | receipt |
| Eric Karras | Chief Commercial Officer | - | receipt |
| Kathy Scott | Chief Financial Officer | receipt | |
| Richard Lowenthal | CEO | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changes
mcp_package_hint
slug ars-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$